Latest GLMD reports update at 2024-04-27: 2023 ∙ 2022 ∙ 2021
  1. Home
  2. Stock quotes
  3. Galmed Pharmaceuticals Ltd.
  4. Financial Ratios
Galmed Pharmaceuticals Ltd. logo
Galmed Pharmaceuticals Ltd. GLMD
$ 0.4 2.7%
mail-toReport an Error

Galmed Pharmaceuticals Ltd. Financial Ratios 2011-2024 | GLMD

Annual Financial Ratios Galmed Pharmaceuticals Ltd.

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.2 -0.1 -0.1 -2.9 -5.0 -15.2 -5.2 -2.7 6.5 7.4 - - -

P/S

 - - - - - 73.3 58.9 98.6 - - - - -

EPS

 2.5 10.7 19.8 1.4 1.0 - - - - - - - -

EV (Enterprise Value)

 - - 2.36 M 85.9 M 93.8 M 128 M 54.8 M 48.3 M 67.9 M 45.1 M 1.98 M 2.02 M -

EBITDA per Share

 - - 0.03 -1.41 -1.06 -0.57 -0.97 -1.47 0.961 0.883 - - -

EV/EBITDA

 - -2.4 -4.4 -11.0 -9.2 -2.6 6.1 4.8 - - -

PEG

 0.1 0.07 -0.07 0.31 0.3 0.01 0.77 -0.06 - - -

P/B

 - - 0.1 1.9 1.5 1.7 4.0 4.2 3.2 2.1 - - -

P/CF

 -0.2 -0.1 -0.1 -3.2 -6.9 -16.6 -5.3 -3.8 -8.0 -6.7 - - -

ROE %

 -49.80 -133.10 -106.46 -65.16 -29.29 -11.21 -77.87 -153.07 49.30 28.98 - - -

ROA %

 -41.57 -107.88 -88.70 -54.93 -26.52 -10.88 -62.61 -103.06 43.78 27.65 - - -

ROCE %

 - - - -68.09 -31.87 -12.19 -78.28 -142.21 48.90 28.62 - - -

Current Ratio

 - - - 6.4 10.6 33.5 5.1 3.4 9.2 28.8 - - -

DSO

 - - - - - 33.4 73.8 23.4 - - - - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Operating Cycle

 - - - - - 33.4 73.8 - - - - - -

Cash Conversion Cycle

 - - - - - 33.4 73.8 - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Galmed Pharmaceuticals Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 - - - - - - 0.33 - - - 0.26 - - - - - - - 0.17 - - - 0.22 - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

 - - - - - - - - - - -0.27 - - - -0.22 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

 - - -18.66 -37.32 -54.13 -35.47 -44.70 -35.27 -27.91 -18.69 -23.81 -19.70 -14.36 -9.23 -12.18 -10.01 -24.32 -21.37 -64.50 -104.68 -86.25 -43.13 -73.01 -59.77 -59.77 -29.88 -29.88 - - - - - - - - - - - - - - - - - - - - -

ROA %

 - - -16.05 -32.09 -32.09 -16.05 -24.57 -17.04 -17.04 -8.52 -13.42 -9.80 -9.80 -4.90 -7.73 -5.66 -5.66 -2.83 -29.68 -53.70 -53.70 -26.85 -50.80 -47.90 -47.90 -23.95 -23.95 - - - - - - - - - - - - - - - - - - - - -

ROCE %

 - - - - - - -9.67 -19.34 -19.34 -9.67 -15.42 -11.49 -11.49 -5.74 -5.74 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 - - - - - - - - - - - - - - - - - - 62.2 - - - 45.0 - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - 62.2 - - - 45.0 - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - 62.2 - - - 45.0 - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency